Cinchophen lithium

This classification denotes a nonsteroidal antiinflammatory drug C16H10NO2.Li, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 17Z71O8Z3D, chemically known as 4-quinolinecarboxylic acid, 2-phenyl-, lithium salt (1:1), but more generally known as cinchophen lithium, which bears US NIH Compound Identifier 71300649. European Medicines Agency schedules Cinchophen lithium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01307MIG. Most nations, for tariff and trade purposes, schedule cinchophen lithium under HS 29334910 and SITC 51575. As of Q4 2014, CINCHOPHEN LITHIUM remains US FDA's Preferred Term for this commodity. SMILES: [LI+].C1CCC(CC1)C2CC(C3CCCCC3N2)C(=O)[O-].